AlphaCrest Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

AlphaCrest Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,500	Closed	-$750K	–	1332
2020 Q3	$750K	Buy	+5,500	New	+$585K	0.08%	375
2020 Q2	–	Sell	-10,252	Closed	-$481K	–	1202
2020 Q1	$481K	Sell	10,252 -1,248	-11%	-$80K	0.06%	587
2019 Q4	$838K	Sell	11,500 -4,200	-27%	-$255K	0.07%	454
2019 Q3	$819K	Buy	15,700 +3,300	+27%	+$175K	0.05%	677
2019 Q2	$622K	Buy	+12,400	New	+$604K	0.05%	613

AlphaCrest Capital Management's MYOK Position: Q4 2020 in Review

AlphaCrest Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 5,500 shares — an estimated $750K sold.

AlphaCrest Capital Management first reported a position in MYOK in Q2 2019 and held it in 5 quarters. The position peaked at $838K in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

AlphaCrest Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
AlphaCrest Capital Management sold 5,500 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $750K.
AlphaCrest Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
AlphaCrest Capital Management's MyoKardia, Inc. Common Stock position peaked at $838K in Q4 2019.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on AlphaCrest Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.